glp-1 mcas Could Medications Be a Game-Changer for MCAS? GLP-1 Therapies May Benefit MPN

For L-Carnitine 3000, it complements K-XR without adding extra stimulants

Risk Factors That May Increase Depression Risk on GLP-1 Patients with a personal or family history of depression, bipolar disorder, or other mood disorders should receive enhanced mental health screening before starting GLP-1 therapy

Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats

Peripheral Neuropathy Supports damaged nerves and improves nerve conduction

Estrogen dominance is the root cause of endometriosis, heavy menstruation aka menorrhagia, PMS, uterine fibroids, dense breast tissue and causes an increased risk of endometrial and breast cancers

doi: 10.1016/j.rmcr.2020.101063 27 IbrahimH